COPD

copd

Episode 208: PREMIUM – COPD, gout and NSAIDs oh my

In episode 208, James and Mike PREMIUM to the max with three interesting studies that could change your practice. We talk about duration of steroids for COPD exacerbations, when to start allopurinol after a gout attack and which NSAIDs are the safest from a cardiovascular perspective. You need to hear all about this!

Show notes Read more »

Episode 191: A New Year brings new questions and some new but mainly old answers – PART III

In episode 191, Mike and James finally get to the end of the latest listener questions. We try our best to answer issues about niacin, insulin, COPD, hypertension and most importantly sputum color. At the end we also question the questioner’s questions, which leads us to even more questioning. Read more »

Episode 153: Roflumilast when you add it on for COPD does it add up?

In episode 153, James and Mike attempt to breath life into a new agent for COPD called roflumilast. Unfortunately, by the end of the podcast we find out that the effect of this agent doesn't leave Mike and James breathless but unfortunately it will leave our COPD patients that way. 

Show notes Read more »

Episode 147: Definitively vague questions with vaguely definitive answers

In episode 147, Mike and James cover the issue of humor in teaching, put drugectomies in LTC facilities into perspective, discuss the use of antibiotics in COPD, and finally contextualize bisphophonates and estrogen for fracture reduction. At the end they agree that the 30 minutes of podcast excellence should leave the audience laughing and crying but not for the right reasons. Read more »

Episode 124: PREMIUM - Two pulmonary studies with useful results and yet again more data on calcium

In episode, 124 James and Mike go all PREMIUM on the podcast and provide our wonderful PREMIUM subscribers with information that will make them much better health care practitioners than those listeners who are not PREMIUM podcast subscribers. Read more »

Episode 39: New trials you need to know about - Part II

In episode 39 we get to the 4 studies we didn’t get to in the previous podcast. We discuss evidence that BMI is as useful as cholesterol when it comes to estimating cardiovascular risk, inhaled corticosteroids increase risk of pneumonia in patients with COPD – but don’t worry just put them on daily erythromycin – and finally we discuss yet another antihypertensive trial. Read more »

Episode 38: New trials you need to know about

In episode 38 we try to go over 8 new studies in one podcast but only get half-way there. We cover 2 inhaled anticholinergic studies, one new glucose lowering trial and the latest smoking cessation RCT. Read more »

Episode 37: Diverse listener questions and comments - Q & A with no QA

In Episode 37, we again review listener questions and comments around such diverse topics as Bell's Palsy, viruses that break bones, glucose monitoring, glitazones and COPD. Both James and Mike give diverse answers with diverse meanings that even they don't really understand.

Show Notes Read more »

Episode 27: COPD: Breathing Life into Effective (& some not) COPD Treatments

In episode 27, we examine the management of COPD Exacerbation and adjunctive treatments. We review the relatively good evidence for antibiotics and steroids in Exacerbations including the options in choice, dosing, and mode of administration. We briefly examination some of the other treatment options in chronic COPD with combination puffers, immunizations, theophyline, and home oxygen. Read more »

Episode 26: COPD: Confusing Overwhelming Puffer Data leaving us Breathless

In episode 26, we examine the initial management of COPD. We first discuss the diagnosis of COPD and if screening is recommended. We encourage an initial focus on smoking cessation and then episodic, symptom control. We then review long acting puffers and the large body of confusing research with underwhelming and at times conflicting results. Read more »

Syndicate content